This presentation examines increasing expectations medicine developers face in order to obtain improved outcomes - from payors, to regulators, and patients. It discusses the role advanced delivery technology providers play when shifting from ensuring achievement of desired delivery profiles to driving therapeutic benefits. This requires developers and technologists to use different approaches, different partnerships, and different mindsets.
The 2nd Annual Partnership Opportunities in Drug Delivery Conference (PODD) is designed to present a strategic level program for pharmaceutical and biotech business development and external licensing professionals. The event provides a thorough overview of the latest drug delivery technologies available as well as provides a platform for professionals to discuss their development and formulation needs. PODD fosters a meeting place that inspires innovation and advancement of drug development and delivery and offers support for the leaders behind the movement.
Mr. Stamoran has more than 20 years of experience in the pharmaceutical industry. Since joining Catalent in 1992, he has held many roles across a variety of disciplines. During his career, Mr. Stamoran has directly participated in the development of patient adherence and outcomes enhancement strategies for more than 150 innovator drugs. He holds a B.S. degree in accounting and management from the University of Michigan.
Companies in this article
